The role of copper transporters in the development of resistance to Pt drugs.

[1]  G. Samimi,et al.  Cross-resistance to cisplatin in cells with acquired resistance to copper , 2004, Cancer Chemotherapy and Pharmacology.

[2]  C. Bucci,et al.  Endosomal trafficking of the Menkes copper ATPase ATP7A is mediated by vesicles containing the Rab7 and Rab5 GTPase proteins. , 2003, Experimental cell research.

[3]  D. Alberts,et al.  Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[5]  G. Samimi,et al.  The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. , 2003, Molecular pharmacology.

[6]  T. Kawaguchi,et al.  Wilson disease protein ATP7B is localized in the late endosomes in a polarized human hepatocyte cell line. , 2003, International journal of molecular medicine.

[7]  Myriam Rochdi,et al.  Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. , 2002, Cancer research.

[8]  S. Howell,et al.  The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. , 2002, Molecular pharmacology.

[9]  K. Ogawa,et al.  Copper‐transporting P‐type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP , 2002, International journal of cancer.

[10]  I. Herskowitz,et al.  Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Kaplan,et al.  Molecular Characterization of hCTR1, the Human Copper Uptake Protein* , 2002, The Journal of Biological Chemistry.

[12]  B. Tops,et al.  Biochemical characterization and subcellular localization of human copper transporter 1 (hCTR1). , 2002, The Biochemical journal.

[13]  D. Thiele,et al.  Molecular mechanisms of copper uptake and distribution. , 2002, Current opinion in chemical biology.

[14]  D. Thiele,et al.  Biochemical Characterization of the Human Copper Transporter Ctr1* , 2002, The Journal of Biological Chemistry.

[15]  K. Ogawa,et al.  Copper‐transporting P‐Type Adenosine Triphosphatase (ATP7B) Is Expressed in Human Breast Carcinoma , 2002, Japanese journal of cancer research : Gann.

[16]  Dominique L. Cosco,et al.  The copper transporter CTR1 provides an essential function in mammalian embryonic development , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Thiele,et al.  Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Zöller,et al.  Antitumoral activity of a sulphur-containing platinum complex with an acidic pH optimum , 2001, Cancer Chemotherapy and Pharmacology.

[19]  W. Sheldrick,et al.  Interaction of cisplatin with methionine- and histidine-containing peptides: competition between backbone binding, macrochelation and peptide cleavage , 2001, JBIC Journal of Biological Inorganic Chemistry.

[20]  K. Bissig,et al.  Expression of the Human Menkes ATPase in Xenopus laevis Oocytes , 2001, Biological chemistry.

[21]  D. Schrenk,et al.  Up-regulation of transporters of the MRP family by drugs and toxins. , 2001, Toxicology letters.

[22]  L. Møller,et al.  Characterization of the hCTR1 gene: genomic organization, functional expression, and identification of a highly homologous processed gene. , 2000, Gene.

[23]  P. Brown,et al.  Identification of the Copper Regulon in Saccharomyces cerevisiae by DNA Microarrays* , 2000, The Journal of Biological Chemistry.

[24]  R. Vonk,et al.  Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. , 2000, Gastroenterology.

[25]  Y. Maehara,et al.  Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  T. Endo,et al.  Carrier-mediated uptake of cisplatin by the OK renal epithelial cell line. , 2000, Toxicology.

[27]  M. Mutoh,et al.  Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. , 2000, Cancer research.

[28]  T. Uchiumi,et al.  Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2) , 1999, FEBS letters.

[29]  Mariko Suzuki1 and Jonathan D Gitlin.  Intracellular localization of the Menkes and Wilson’s disease proteins and their role in intracellular copper transport , 1999, Pediatrics international : official journal of the Japan Pediatric Society.

[30]  Natsuko Suzuki,et al.  Rupture of coronary aneurysm in Kawasaki disease , 1999, Pediatrics international : official journal of the Japan Pediatric Society.

[31]  T. O’Halloran,et al.  Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. , 1999, Science.

[32]  J. Camakaris,et al.  A C-terminal di-leucine is required for localization of the Menkes protein in the trans-Golgi network. , 1998, Human molecular genetics.

[33]  K. Kohno,et al.  Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. , 1998, Biochemical and biophysical research communications.

[34]  M. Czaja,et al.  Copper resistant human hepatoblastoma mutant cell lines without metallothionein induction overexpress ATP7B , 1998, Hepatology.

[35]  J Christodoulou,et al.  Cisplatin Binding Sites on Human Albumin* , 1998, The Journal of Biological Chemistry.

[36]  T. Uchiumi,et al.  A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. , 1997, Cancer research.

[37]  J. Kaplan,et al.  Heterologous Expression of the Metal‐Binding Domains of Human Copper‐Transporting ATPases (P1‐ATPases) a , 1997, Annals of the New York Academy of Sciences.

[38]  S. Packman,et al.  Mutation Analysis and Expression of the Mottled Gene in the Macular Mouse Model of Menkes Disease , 1997, Pediatric Research.

[39]  R. Casareno,et al.  The Copper Chaperone for Superoxide Dismutase* , 1997, The Journal of Biological Chemistry.

[40]  Bing Zhou,et al.  hCTR1: a human gene for copper uptake identified by complementation in yeast. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Glerum,et al.  Isolation of a cDNA encoding the human homolog of COX17, a yeast gene essential for mitochondrial copper recruitment , 1997, Human Genetics.

[42]  K. Kohno,et al.  A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. , 1996, Cancer research.

[43]  C. Vulpe,et al.  CPx-type ATPases: a class of P-type ATPases that pump heavy metals. , 1996, Trends in biochemical sciences.

[44]  L. Kèlland,et al.  Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  S. Howell,et al.  Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cells. , 1995, The Journal of clinical investigation.

[46]  S. Howell,et al.  Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line. , 1994, Cancer Research.

[47]  T. Gilliam,et al.  Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. , 1994, Human molecular genetics.

[48]  V. C. Yang,et al.  Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells. , 1994, The Biochemical journal.

[49]  M. Zhang,et al.  Amelioration of Cisplatin Toxicity in Rat Renal Cortical Slices by Dithiothreitol In vitro , 1994, Human & experimental toxicology.

[50]  J. Peppercorn,et al.  The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene , 1993, Nature Genetics.

[51]  J. Rommens,et al.  The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.

[52]  J. Gitlin,et al.  Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. , 1993, Biochemical and biophysical research communications.

[53]  L. Smets,et al.  Potentiation of dna‐adduct formation and cytotoxicity of platinum‐containing drugs by low pH , 1993, International journal of cancer.

[54]  P. Andrews,et al.  Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells. , 1991, Cancer research.

[55]  S. Howell,et al.  Short-termcis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells , 2004, Cancer Chemotherapy and Pharmacology.

[56]  S. Lutsenko,et al.  Function and Regulation of the Mammalian Copper-transporting ATPases: Insights from Biochemical and Cell Biological Approaches , 2003, The Journal of Membrane Biology.

[57]  Thomas W. Glover,et al.  Isolation of a partial candidate gene for Menkes disease by positional cloning , 1993, Nature Genetics.

[58]  R. Bhola,et al.  Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro. , 1993, Archivum immunologiae et therapiae experimentalis.

[59]  Anthony P. Monaco,et al.  Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein , 1993, Nature Genetics.

[60]  S. Packman,et al.  Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper–transporting ATPase , 1993, Nature Genetics.